Haemoglobin D disease

Description

Haemoglobin D (Hb D) disease is characterised by mild haemolytic anaemia and mild to moderate splenomegaly. Prevalence is unknown. Heterozygous forms of Hb D are clinically silent. Molecular testing can be useful to distinguish Hb D homozygosity from cases of heterozygous Hb D in association with beta-(0) thalassaemia.

Index terms

Haemoglobin D disease
Hb D Los Angeles disease
Hb D Punjab disease

Show allHide

Los Angeles disease
Punjab disease

Exclusions from above levels

04 – Diseases of the immune system
05 – Endocrine, nutritional or metabolic diseases
18 – Complications of pregnancy, childbirth or the puerperium

Show allHide

19 – Certain conditions originating in the perinatal period
20 – Congenital malformations, deformations or chromosomal abnormalities
22 – Injury, poisoning or certain other consequences of external causes
http://id.who.int/icd/entity/1000704511 – Human immunodeficiency virus disease
JB64.1 – Other diseases of the blood or blood-forming organs or certain disorders involving the immune mechanism complicating pregnancy, childbirth or the puerperium

Sibling codes

3A51.0 – Sickle cell trait
3A51.1 – Sickle cell disease without crisis
3A51.2 – Sickle cell disease with crisis
3A51.3 – Compound heterozygous sickling disorders without crisis
3A51.4 – Compound heterozygous sickling disorders with crisis
3A51.5 – Haemoglobin C disease
3A51.7 – High affinity haemoglobin
3A51.8 – Low affinity haemoglobin
3A51.9 – Haemoglobin O disease
3A51.A – Haemoglobin E disease
3A51.B – Haemoglobin C/beta thalassaemia compound heterozygosity
3A51.Y – Other specified sickle cell disorders or other haemoglobinopathies
3A51.Z – Sickle cell disorders or other haemoglobinopathies, unspecified

Foundation entity

Haemoglobin D disease – http://id.who.int/icd/entity/1508363690

Part of: 3A51: Sickle cell disorders or other haemoglobinopathies › 03: Diseases of the blood or blood-forming organs